A
4.22
-0.03 (-0.71%)
| Previous Close | 4.25 |
| Volume | 881,632 |
| Price / Sales | 10.34 |
| Price / Book | 1.90 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.630 |
| Total Debt/Equity (MRQ) | 57.92% |
| Current Ratio (MRQ) | 4.90 |
| Operating Cash Flow (TTM) | -59.88 M |
| Levered Free Cash Flow (TTM) | -39.71 M |
| Return on Assets (TTM) | -49.95% |
| Return on Equity (TTM) | -271.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Abeona Therapeutics Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.1 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | -0.5 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.08 |
Select this tab to load the latest available analysis.
|
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 5.84% |
| % Held by Institutions | 63.35% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Onedigital Investment Advisors Llc | 30 Jun 2026 | 1,653,024 |
| Nan Fung Trinity (Hk) Ltd | 30 Jun 2026 | 956,770 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |